"Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines. 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK). In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control)." Scope of the Report: This report focuses on the Pneumococcal Vaccine in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Pfizer GSK MSD Sanofipasteur CDIBP Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers PPSV 23 PCV 7/13 PCV 10 Market Segment by Applications, can be divided into Child Adult There are 15 Chapters to deeply display the North America Pneumococcal Vaccine market. Chapter 1, to describe Pneumococcal Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Pneumococcal Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Pneumococcal Vaccine, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Pneumococcal Vaccine market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Pneumococcal Vaccine Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Pneumococcal Vaccine Introduction 1.2 Market Analysis by Type 1.2.1 PPSV 23 1.2.2 PCV 7/13 1.2.3 PCV 10 1.3 Market Analysis by Applications 1.3.1 Child 1.3.2 Adult 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Mexico Status and Pro
